Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.
about
A small mitochondrial protein present in myzozoans is essential for malaria transmission.Transition of Plasmodium sporozoites into liver stage-like forms is regulated by the RNA binding protein PumilioRON12, a novel Plasmodium-specific rhoptry neck protein important for parasite proliferation.Enlightening the malaria parasite life cycle: bioluminescent Plasmodium in fundamental and applied researchRemoval of heterologous sequences from Plasmodium falciparum mutants using FLPe-recombinaseA novel 'gene insertion/marker out' (GIMO) method for transgene expression and gene complementation in rodent malaria parasitesEnzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium bergheiSequestration and Tissue Accumulation of Human Malaria Parasites: Can We Learn Anything from Rodent Models of Malaria?Proteomic and genetic analyses demonstrate that Plasmodium berghei blood stages export a large and diverse repertoire of proteinsDistinct properties of the egress-related osmiophilic bodies in male and female gametocytes of the rodent malaria parasite Plasmodium bergheiThe novel putative transporter NPT1 plays a critical role in early stages of Plasmodium berghei sexual developmentVariant Exported Blood-Stage Proteins Encoded by Plasmodium Multigene Families Are Expressed in Liver Stages Where They Are Exported into the Parasitophorous VacuoleDistinct placental malaria pathology caused by different Plasmodium berghei lines that fail to induce cerebral malaria in the C57BL/6 mouse.Imaging Plasmodium immunobiology in the liver, brain, and lung.A unique profilin-actin interface is important for malaria parasite motilityProtection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage Plasmodium berghei parasites.Glutathione reductase-null malaria parasites have normal blood stage growth but arrest during development in the mosquitoProtease-associated cellular networks in malaria parasite Plasmodium falciparum.Loss-of-function analyses defines vital and redundant functions of the Plasmodium rhomboid protease family.Replication of Plasmodium in reticulocytes can occur without hemozoin formation, resulting in chloroquine resistance.Imperfect duplicate insertions type of mutations in plasmepsin V modulates binding properties of PEXEL motifs of export proteins in Indian Plasmodium vivax.Plasmodium Cysteine Repeat Modular Proteins 3 and 4 are essential for malaria parasite transmission from the mosquito to the host.Noninvasive biophotonic imaging for studies of infectious disease.Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?A genome-scale vector resource enables high-throughput reverse genetic screening in a malaria parasiteCharacterization and tissue-specific expression patterns of the Plasmodium chabaudi cir multigene family.Disruption of plasmepsin-4 and merozoites surface protein-7 genes in Plasmodium berghei induces combined virulence-attenuated phenotype.Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo.Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria.Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches.Aspartyl Proteinases of Eukaryotic Microbial Pathogens: From Eating to HeatingThe utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.An ultrasensitive NanoLuc-based luminescence system for monitoring Plasmodium berghei throughout its life cycleMurine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in PregnancyMultidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites.Protection against malaria in mice is induced by blood stage-arresting histamine-releasing factor (HRF)-deficient parasitesUnderstanding the structural basis of substrate recognition by Plasmodium falciparum plasmepsin V to aid in the design of potent inhibitors.Cytoadherence of Plasmodium berghei-infected red blood cells to murine brain and lung microvascular endothelial cells in vitro.Protective immunity against malaria after vaccination.
P2860
Q27336393-B9A36068-FD7E-4813-9ED3-56965A030EBAQ27349937-FC34DE5D-1A45-4711-96E0-3A46E6B0F44DQ27973901-237F4C14-FBAB-47D0-8E88-03355BECD841Q28085135-F9F317F2-0120-42E4-9688-1C80001C0112Q28476396-6212B5BA-B048-4CF0-9BE7-FAD9CE50A797Q28478600-0F7F2E7F-3B4F-41F0-AF14-D8BC2F4C0A38Q28550537-7C8F9CE4-F679-48F6-9F7B-24BC870D7421Q29396069-D0104D8D-3210-4A07-A80F-01B73456C9F3Q30040949-9AC7EE61-BE3E-4673-ADE7-E10E01258A84Q30041464-3C53C270-E9F3-473D-BC3E-B1DE90F465B4Q30041784-10F21C6D-ABA0-4239-993C-8FA73BF0CFC1Q30047429-91982A69-2357-4EB6-A077-A31B7B6F3B5BQ30527844-8D74EFAE-F70D-4A70-BE9F-BE7007947565Q30561036-611FC737-F7C5-43F3-8069-F7102F9687F8Q33778851-29248C54-BB00-457D-BF78-C7E3D66A87A7Q34026083-03E50FBA-DAE4-4B4C-A347-4BF2D9CD8563Q34094450-B25579A2-7F98-4B9D-94E2-576D5EF2123EQ34173524-72200B2A-132B-4736-97D3-F04700793A3EQ34332951-FDB36A40-7E46-4FC8-A2B9-DDADEAD2E527Q34475026-1D8552DB-28AC-4ACD-8D40-4D2502F1FEDAQ34653196-C7C0FCAA-FE4D-42A8-8956-5ED8BB9C109EQ34871838-A83E3E89-99F2-4999-BB5D-6E11FF61C37AQ34886067-8E71625F-FFFC-4D8F-9A13-F59F8B291768Q34983659-1DDCCD2E-B554-41FD-ACC3-7B54D9965166Q35185939-2D1F5036-E48C-493D-BA66-C838BAFBCA4CQ35290520-D72FC840-1312-42E7-A714-3038B346D2A0Q35551353-C7A54B16-B1BF-44EE-AE6B-5BB726547787Q35679569-F8DF11C9-B81A-4D77-AA09-227F33E3F2B9Q35745551-8EB4A1A8-8AAA-400D-B076-8477B5B3BE55Q36100829-36F25F6F-C47E-47D6-B142-5A53C63D2561Q36209383-1A077090-69F8-433C-A4A0-6827D13F111BQ36231575-1E5CE607-7BE1-4209-B917-9D109A368254Q36785777-9670C7E5-8A98-4B7E-A269-D80F96FABC5CQ36825361-98348592-447D-4C26-ADF2-8B8A6F208B66Q37002285-1CF95BC6-F112-40F0-8E7E-E24255406BAAQ37173948-654AFF38-58F0-4096-8F99-E3E00D87FD99Q37179042-6E835D03-146E-4485-8ADF-11F6DE75FD31Q37181425-5792018A-01C5-41BC-8F3D-8D83E06A7378Q37264802-EC88930B-AB1D-4362-995C-6E60CAF0B394Q38159714-EA00CA2C-58FC-4717-B1CC-B0624BF7666D
P2860
Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@ast
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@en
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@nl
type
label
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@ast
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@en
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@nl
prefLabel
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@ast
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@en
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@nl
P2093
P2860
P50
P921
P1476
Plasmepsin 4-deficient Plasmod ...... against experimental malaria.
@en
P2093
Andrea Savarino
Andrew P Waters
Antonio Cassone
Francesco Bistoni
J Alfredo Bonilla
John B Dame
Luke M Syphard
Roberta Spaccapelo
Sara Caterbi
Tania Dottorini
P2860
P304
P356
10.2353/AJPATH.2010.090504
P407
P577
2009-12-17T00:00:00Z